Avalo Therapeutics AVTX
NASDAQ AVTX
$8.51 +1.35 (+18.78%)
As of: Nov 11, 2026 · 3:59 PM EST

Avalo Therapeutics (AVTX) Other financing activities (as filed) (2014 - 2026)

Updated

Avalo Therapeutics' Other financing activities came in at $779,000 for Q1 2026.

Analysis

Avalo Therapeutics (AVTX) Other financing activities (as filed) (2014 - 2026) Analysis & Trends

For FY2025, Avalo Therapeutics' Other financing activities was $510,000.

  • Other financing activities carries a five-year compound annual growth rate of 40.2% (FY2020 to FY2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Avalo Therapeutics 386.09 Mn -587.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 211,000.00
Jun 30, 2026 49,000.00
Mar 31, 2026 -779,000.00
Dec 31, 2025 -462,000.00
Sep 30, 2025 90,000.00
Jun 30, 2025 20,000.00
Dec 31, 2024 -1.73 Mn
Sep 30, 2024 41,000.00
Mar 31, 2024 -7.01 Mn
Dec 31, 2023 1.00 Mn
Sep 30, 2023 1,000.00
Jun 30, 2023 15,000.00
Dec 31, 2022 -38,000.00
Sep 30, 2022 39,000.00
Jun 30, 2022 -86,000.00
Mar 31, 2022 100,000.00
Jun 30, 2021 -153,000.00
Mar 31, 2021 153,000.00
Jun 30, 2020 -94,000.00
Dec 31, 2019 -314,021.00
API Access

Avalo Therapeutics Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=AVTX&period=max&api_key=YOUR_API_KEY